Swine Dysentery: Age Susceptibility, Causative Agent, and Clinical Management in Pigs

Introduction

Swine dysentery (SD) is a contagious, mucohemorrhagic colitis that affects pigs worldwide, causing substantial economic losses in commercial swine production systems due to mortality, reduced growth performance, and increased medication costs. The disease is defined by inflammation and necrosis of the cecum and colon, clinically presenting as diarrhea with mucus and fresh blood. Understanding the causative agent, host age dynamics, and evidence-based clinical management is critical for effective herd-level control.

This article provides an exhaustive technical review of Brachyspira hyodysenteriae pathogenesis, age-related susceptibility patterns in pigs, diagnostic modalities, and therapeutic and preventive approaches. Cross-references to related enteric and bacterial conditions such as Porcine Proliferative Enteropathy: Lawsonia intracellularis Diagnosis and Control in Swine Herds and Livestock Zoonoses: A Comprehensive Overview of Bacterial and Viral Diseases Transmitted from Farm Animals to Humans provide broader context.

Causative Agent: Brachyspira hyodysenteriae

Taxonomy and Morphology

Swine dysentery is primarily caused by Brachyspira hyodysenteriae, a Gram-negative, anaerobic, spirochete bacterium belonging to the family Brachyspiraceae within the phylum Spirochaetes. Other Brachyspira species (e.g., B. pilosicoli, B. innocens, B. murdochii) are either weakly hemolytic or nonpathogenic; B. pilosicoli causes porcine intestinal spirochetosis, a milder colitis. B. hyodysenteriae is distinguished by its strong beta-hemolysis on blood agar and distinct phenotypic and genotypic characteristics.

The organism measures 6 to 10 micrometers in length and 0.3 to 0.4 micrometers in diameter, with a characteristic helical morphology conferred by periplasmic flagella (axial filaments) that enable corkscrew motility in viscous environments. The cell envelope consists of an outer membrane, a peptidoglycan layer, and a cytoplasmic membrane. The genome is approximately 3.0 to 3.2 Mb with a G+C content of 27 mol%.

Pathogenesis Mechanisms

B. hyodysenteriae colonizes the colonic and cecal mucosa, specifically the crypt lumen and goblet cells. The sequence of pathogenic events includes:

1. Chemotaxis and mucosal penetration: The spirochete uses chemotactic sensors to navigate through the mucus layer toward the epithelial surface. Its corkscrew motility and secretion of mucinolytic enzymes, including a NADH oxidase and superoxide dismutase, allow it to survive oxygen gradients and degrade mucus.

2. Adhesion: Adhesion is mediated by surface proteins such as Bhlp (Brachyspira hyodysenteriae lipoprotein) and glycolipid-binding outer membrane proteins. The organism adheres to the apical surface of colonic enterocytes and penetrates intercellular tight junctions via paracellular invasion.

3. Cytotoxicity and inflammation: Secretion of hemolysins (beta-hemolysin and phospholipase C-like enzymes) and lipooligosaccharide (LOS) triggers epithelial cell injury and a robust neutrophilic inflammatory response. Proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) are upregulated, leading to mucosal edema, erosion, and pseudomembrane formation. The result is hemorrhagic exudation and epithelial sloughing.

4. Immune evasion: The spirochete undergoes antigenic variation of surface lipoproteins and resists complement-mediated killing by binding host factor H. This contributes to chronic colonization and recurrent outbreaks.

Transmission and Environmental Persistence

Pigs are infected via the fecal-oral route, ingesting contaminated feed, water, or bedding. B. hyodysenteriae can survive in feces for up to 60 days at 10 degrees Celsius and for 7 days at 25 degrees Celsius. Its survival in lagoon water, slurry pits, and moist environments facilitates transmission between production groups. The minimum infectious dose in susceptible swine is approximately 10^5 to 10^7 organisms.

Age Susceptibility: Swine Dysentery in Pigs of Different Age Groups

Age is a critical determinant of clinical expression and disease severity. Swine dysentery is most commonly observed in growing and finishing pigs between 6 and 16 weeks of age. The following table summarizes age-related susceptibility patterns:

Age-Mediated Mechanisms

The age-dependent dynamics are governed by immunological maturation and microbial community succession. Piglets acquire maternal anti-Brachyspira IgA through colostrum, which protects the intestinal mucosa for the first 2 to 3 weeks. As maternal antibody titers decline, the juvenile gut undergoes a period of microbial instability that favors colonization by anaerobic spirochetes. The ileocolic junction and proximal colon are the primary sites of adhesion due to higher mucus viscosity and lower pH regulation in younger pigs.

Interestingly, pigs under 4 weeks of age often lack the host epithelial receptors required for strong hemolysin-mediated cytotoxicity. Experimental inoculation studies demonstrate that weaned piglets develop milder lesions than 8-week-old growers. Conversely, pigs over 20 weeks of age show reduced severity due to regulatory T cell responses and increased mucin production that entraps spirochetes.

Clinical Signs and Pathological Lesions

Clinical Presentation

The incubation period ranges from 3 to 14 days after natural exposure. Initial signs include reduced feed intake, depression, and soft, yellow-gray feces. Within 24 to 48 hours, diarrhea becomes watery and contains fresh blood, mucus, and fibrin casts. The classic description is "hemorrhagic mucoid diarrhea" with a distinct fetid odor. Affected pigs show marked dehydration (10-15% body weight loss), arched back, and straining. Rectal temperature may rise to 40.5 degrees Celsius during the acute phase but often normalizes as colitis progresses.

Chronic forms manifest as intermittent pasty to watery feces with variable blood content; pigs become "poor doers" with stunted growth. Case fatality in acute outbreaks can reach 30% in untreated groups, with most deaths occurring 3 to 7 days after onset.

Gross Pathology

Necropsy reveals a thickened, edematous cecal and colonic wall with hyperemic mucosa. The lumen contains a mixture of yellow to brown hemorrhagic fluid and flecks of necrotic epithelium. In severe cases, the colonic mucosa is covered by a pseudomembrane composed of fibrin, neutrophils, and sloughed cells. The small intestine is typically unaffected, which differentiates SD from other porcine enteropathies.

Histopathology

Microscopic findings include necrosis of surface and crypt epithelial cells, neutrophilic infiltration into the lamina propria and crypt lumina (crypt abscesses), and goblet cell hyperplasia. Silver stains (e.g., Warthin-Starry) or immunohistochemistry reveals spirochetes in large numbers within the crypt lumen and adherent to enterocytes.

Diagnostic Methods

Accurate diagnosis of swine dysentery requires a combination of clinical history, necropsy findings, and laboratory confirmation. The differential diagnosis includes porcine proliferative enteropathy (Lawsonia intracellularis), salmonellosis (Salmonella enterica serovars), porcine intestinal spirochetosis (B. pilosicoli), tricomonad colitis, and diet-induced mucohemorrhagic syndrome. The following subsections present the standard diagnostic workflow.

Traditional Bacteriology

Fecal or mucosal swabs are cultured on selective media containing spectinomycin (400 mg/L), colistin (25 mg/L), and vancomycin (25 mg/L) under anaerobic conditions at 37 degrees Celsius for 3 to 5 days. B. hyodysenteriae forms a distinctive zone of strong beta-hemolysis (complete clearing) on trypticase soy agar with 5% sheep or bovine blood. Weakly beta-hemolytic isolates (B. pilosicoli) produce a narrow zone of incomplete hemolysis. Subculture and biochemical tests (indole production, hippurate hydrolysis, alpha-glucosidase activity) help differentiate species.

Molecular Diagnostics

PCR-based assays have largely replaced culture for routine diagnosis due to higher sensitivity, faster turnaround, and ability to detect nonviable organisms. Specific genomic targets include:

• 16S rRNA gene (genus-level detection)
• NADH oxidase gene (nox) (species-level identification for B. hyodysenteriae)
• tlyA gene (hemolysin gene)

Real-time PCR (qPCR) allows quantification of spirochete load and is used to monitor treatment efficacy. Multiplex PCR panels that simultaneously detect B. hyodysenteriae, B. pilosicoli, L. intracellularis, and Salmonella spp. are commercially available and recommended for comprehensive enteric disease investigation. The relative performance of diagnostic tests is shown below:

Serology

Serological assays (commercial ELISA kits) detect IgG antibodies against B. hyodysenteriae lipooligosaccharide or whole-cell antigens. Serology is useful for herd-level exposure assessment but not for acute diagnosis because antibodies appear 10 to 14 days post-infection. Paired serology (acute and convalescent) can confirm recent infection. Note the related article on Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus provides analogous principles of antigen capture ELISA, though with different targets.

Advanced Imaging and Metagenomics

Computed tomography is not used in live pigs for SD diagnosis, but colonoscopy with mucosal biopsy is occasionally employed in research settings. Metagenomic next-generation sequencing of fecal samples can identify Brachyspira species and characterize antimicrobial resistance gene profiles, though this remains primarily a research tool.

Clinical Management: Treatment and Control

Antimicrobial Therapy

Historically, swine dysentery was treated with in-feed or water-soluble antibiotics. However, widespread antimicrobial resistance has compromised the efficacy of many drugs. Susceptibility testing (broth microdilution or disc diffusion) is recommended before therapy.

Commonly used antimicrobials include:

• Tiamulin (pleuromutilin) at 10-15 mg/kg body weight intramuscularly for 3 days or in-feed at 30-100 ppm for 10-14 days. Tiamulin is the drug of choice in many regions but resistance is increasing.
• Valnemulin (pleuromutilin) at 10-25 ppm in feed; higher cost but lower minimum inhibitory concentrations (MICs) against resistant strains.
• Lincomycin (lincosamide) at 100-200 ppm in feed or 5-10 mg/kg intramuscularly for 3-5 days.
• Tylosin (macrolide) at 100-200 ppm in-feed; variable efficacy due to resistance.
• Doxycycline (tetracycline) at 300-500 ppm in feed; limited to reducing fecal shedding.
• Carbadox (quinoxaline) at 25-50 ppm in feed; effective but banned in many countries due to carcinogenicity concerns.

Resistant B. hyodysenteriae strains have been reported for all classes. Resistance to tiamulin is associated with mutations in 23S rRNA and ribosomal protein L3 genes. Multidrug-resistant clones circulate globally, requiring culture and MIC testing for informed therapy.

Supportive Care

Fluid therapy (oral or intravenous) and electrolyte replacement reduce mortality in acutely dehydrated pigs. Oral rehydration solutions containing glucose, sodium, potassium, and chloride can be administered via drinking water. Nonsteroidal anti-inflammatory drugs (e.g., meloxicam) are used to ameliorate abdominal pain and reduce inflammation, although data on efficacy in colitis specifically are limited.

Biosecurity and Herd Management

Because B. hyodysenteriae can survive in the environment and is carried by subclinically infected pigs, control relies on all-in/all-out management, thorough cleaning and disinfection, and isolation of affected groups. The organism is inactivated by 2% sodium hypochlorite, 1% potassium peroxymonosulfate, and 3% cresylic acid at 25 degrees Celsius for 10 minutes.

Partial depopulation and medicated early weaning are employed in farrow-to-finish herds to break the transmission cycle. Feed-based antibiotics are often used for metaphylaxis in recently weaned pigs during high-risk periods.

Vaccination

Effective commercial vaccines are not widely available. Experimental vaccines using bacterins, outer membrane vesicles, or recombinant proteins (e.g., Bhmp39, NADH oxidase) have shown partial protection in challenge studies but none have achieved commercial licensure. The antigenic variability of surface lipoproteins complicates vaccine development.

Integrated Diagnostic Workflow

The following Mermaid diagram illustrates a decision tree for diagnosing and managing suspected swine dysentery outbreaks at the herd level.

flowchart TD
    A[Clinical suspicion: hemorrhagic mucoid diarrhea in grower-finisher pigs], > B{Perform fecal sampling}
    B, > C[Fresh fecal samples from >5 affected pigs]
    C, > D[qPCR for B. hyodysenteriae + differential panel]
    D, > E{Result}
    E, Positive for B. hyodysenteriae, > F[Confirm with culture/MIC if treatment failure suspected]
    E, Negative, > G[Consider alternative etiologies: L. intracellularis, Salmonella, B. pilosicoli]
    F, > H[Select antimicrobial based on MIC profile]
    H, > I[Administer via water or feed for 10-14 days]
    I, > J[Re-test 14 days post-treatment: qPCR from sentinel pigs]
    J, Negative, > K[Maintain biosecurity; all-in/all-out]
    J, Positive, > L[Consider resistance: perform MIC + change drug class]
    L, > H
    G, > M[Further diagnostics: necropsy, histology, culture for salmonella]
    M, > N[Implement etiology-specific treatment]
    N, > K

Prognosis and Economic Impact

With prompt antimicrobial therapy, recovery occurs in 5 to 10 days, but production losses from reduced average daily gain and feed efficiency persist for weeks. Mortality in treated outbreaks is 1 to 5%, versus 10 to 30% in untreated groups. Chronically infected herds experience recurrent cycles, leading to a 15 to 25% reduction in market weight and increased medication costs. Eradication through depopulation-repopulation or partial depopulation with medication is cost-effective for high-health status herds.

Conclusion

Swine dysentery remains a significant challenge in intensive pig production. The causative agent, Brachyspira hyodysenteriae, demonstrates sophisticated pathogenic mechanisms for mucosal colonization and inflammation. Age susceptibility peaks in the grower-finisher stage, driven by immunological and microbiological transitions. Modern diagnostics, particularly real-time PCR, enable rapid pathogen identification and resistance profiling. While antimicrobial therapy is the cornerstone of clinical management, increasing resistance underscores the need for improved biosecurity, herd management, and future vaccine development. Integration of molecular surveillance with antimicrobial stewardship is essential for sustainable control.

References

[1] Hampson DJ. The spirochete Brachyspira hyodysenteriae. In: Gyles CL, Prescott JF, Songer JG, Thoen CO, editors. Pathogenesis of Bacterial Infections in Animals. 4th ed. Ames: Blackwell Publishing; 2010. p. 331-346.

[2] Hidalgo A, Carvajal A, García-Feliz C, Osorio J, Rubio P. Antimicrobial susceptibility testing of Spanish field isolates of Brachyspira hyodysenteriae. Research in Veterinary Science. 2009;87(1):7-12.

[3] La T, Phillips ND, Hampson DJ. Development of a duplex PCR assay for detection of Brachyspira hyodysenteriae and Brachyspira pilosicoli in pig feces. Journal of Clinical Microbiology. 2003;41(7):3372-3375.

[4] Alvarez-Ordóñez A, Martínez-Lobo FJ, Arguello H, Carvajal A, Rubio P. Swine dysentery: aetiology, pathogenesis, diagnosis and treatment. Veterinary Journal. 2013;197(2):143-150.

[5] Burrough ER. Swine dysentery: Etiopathogenesis and diagnosis. Veterinary Clinics of North America: Food Animal Practice. 2012;28(2):329-340.